Hailey L. Gosnell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hailey L. Gosnell has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Amanda Lofgreen
3 shared publications- Balaram Puligandla
Department of Pathology, Oregon Health & Science University, Portland, OR, USA
3 shared publications Cindy B. McCloskey
3 shared publicationsDouglas J. Grider
Division of Dermatology, Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA; and
3 shared publicationsJohn M. Childs
3 shared publicationsKristen Johnson
3 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Elsevier in Academic Pathology
- Vol. 13 (4)
Impact of the hidden curriculum and unprofessionalism on medical student specialty choice
- 10 September 2026
- Published by Elsevier in Academic Pathology
- Vol. 13 (4)
Open AccessImpact of the hidden curriculum and unprofessionalism on medical student specialty choice
- 14 November 2025
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 164 (6) , 908-916
Hepatocellular adenomas with high-risk molecular alterations undetected by “high-risk” β-catenin and/or glutamine synthetase staining patterns
Objective: β-Catenin–mutated hepatocellular adenomas (HCAs) carry an increased malignant transformation risk and are screened by interpreting glutamine synthetase (GS) and β-catenin by immunohistochemistry (IHC). Our study aims to assess GS and β-catenin interpretation guidelines for applicability and reproducibility in predicting high-risk HCA and other relevant molecular alterations. Methods: Hematoxylin and eosin (H&E), β-catenin, GS, and CD34 stains from 75 HCAs were interpreted by three pathologists using Method A (GS interpretation: negative, perivenular patchy, map-like, diffuse, and indeterminate) and Method B criteria (similar GS interpretation scheme based on a recent publication, with and without CD34 expression patterns). Ease of application and interpretation confidence level were assessed. High-risk IHC was defined as nuclear β-catenin and/or diffuse homogeneous GS. Molecular testing was performed on a subset of HCAs and controls. Results: There were 57 resections and 18 biopsy specimens examined. Methods A and B (GS only) were rated as easy to apply, with high interpretation confidence (≥90% using both methods). Consensus rate was comparable in biopsy specimens (100% for both methods) and resections (88% for Method A, 93% for Method B). While the same cases were stratified into high-risk GS categories using both systems, clinically significant genetic alterations (TERT promoter, EGFR, MTOR, and TP53) were identified in 25% of cases stratified as not high risk by IHC. Conclusions: Both methods have a similar ease of application and level of interpretation confidence, and they also detected β-catenin mutations as expected. Other relevant molecular alterations associated with risk of neoplastic progression and/or bleeding were detected in 25% of HCAs with the non-high-risk IHC phenotype, suggesting the value of molecular testing in this subset.
- 14 November 2025
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 164 (6) , 908-916
Hepatocellular adenomas with high-risk molecular alterations undetected by “high-risk” β-catenin and/or glutamine synthetase staining patterns
Objective: β-Catenin–mutated hepatocellular adenomas (HCAs) carry an increased malignant transformation risk and are screened by interpreting glutamine synthetase (GS) and β-catenin by immunohistochemistry (IHC). Our study aims to assess GS and β-catenin interpretation guidelines for applicability and reproducibility in predicting high-risk HCA and other relevant molecular alterations. Methods: Hematoxylin and eosin (H&E), β-catenin, GS, and CD34 stains from 75 HCAs were interpreted by three pathologists using Method A (GS interpretation: negative, perivenular patchy, map-like, diffuse, and indeterminate) and Method B criteria (similar GS interpretation scheme based on a recent publication, with and without CD34 expression patterns). Ease of application and interpretation confidence level were assessed. High-risk IHC was defined as nuclear β-catenin and/or diffuse homogeneous GS. Molecular testing was performed on a subset of HCAs and controls. Results: There were 57 resections and 18 biopsy specimens examined. Methods A and B (GS only) were rated as easy to apply, with high interpretation confidence (≥90% using both methods). Consensus rate was comparable in biopsy specimens (100% for both methods) and resections (88% for Method A, 93% for Method B). While the same cases were stratified into high-risk GS categories using both systems, clinically significant genetic alterations (TERT promoter, EGFR, MTOR, and TP53) were identified in 25% of cases stratified as not high risk by IHC. Conclusions: Both methods have a similar ease of application and level of interpretation confidence, and they also detected β-catenin mutations as expected. Other relevant molecular alterations associated with risk of neoplastic progression and/or bleeding were detected in 25% of HCAs with the non-high-risk IHC phenotype, suggesting the value of molecular testing in this subset.
- Open Access
- 26 October 2025
- Published by Elsevier in Academic Pathology
- Vol. 12 (4)
Perceived gaps in preparation for pathology residency and opportunities for improvement
- 26 October 2025
- Published by Elsevier in Academic Pathology
- Vol. 12 (4)
Open AccessPerceived gaps in preparation for pathology residency and opportunities for improvement
- Open Access
- 23 September 2025
- Published by Elsevier in Academic Pathology
- Vol. 12 (4) , 100221
Barriers to achieving graduated responsibility: preparing pathology residents for independent practice
- 23 September 2025
- Published by Elsevier in Academic Pathology
- Vol. 12 (4) , 100221
Open AccessBarriers to achieving graduated responsibility: preparing pathology residents for independent practice
- 22 October 2024
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
Diagnostic incidence and pitfalls of rete testis hyperplasia and hyaline globules in a multi-institutional study of 348 testicular germ cell tumors
Objectives: The concept of rete hyperplasia with hyaline globules simulating testicular yolk sac tumor was first reported in a mostly retrospective review over 30 years ago. Nonetheless, we continue to encounter examples where this scenario resulted in misdiagnosis. Herein, we sought to investigate the incidence of rete hyperplasia/hyaline globules in germ cell tumors and their associated subtypes and hypothesize an etiology. Methods: A consecutive series of 348 germ cell tumor orchiectomies was evaluated for the presence of rete hyperplasia and hyaline globules, with clinicopathologic features recorded. Results: The incidence of rete hyperplasia and/or hyaline globules in our cohort was 30%, with 56% of specimens with rete hyperplasia containing concomitant hyaline globules. Hyaline globules were more often identified in specimens with nonfocal rete hyperplasia (78%) vs focal rete hyperplasia (22%). Absence of a yolk sac tumor component was seen in over half (61%) of orchiectomies with concurrent rete hyperplasia/hyaline globules (n = 105), inclusive of tumors with “pure” subtypes (ie, pure seminoma, pure teratoma, or pure embryonal carcinoma). Of these 105 specimens, rete invasion was seen in only 48%; notably, Paneth cell–like metaplasia was identified in efferent ductules/epididymis in 13%. Conclusions: Rete hyperplasia and hyaline globules are not uncommon findings in the setting of germ cell tumors (including occurrences in various pure/mixed germ cell tumors) and can show striking overlap with yolk sac tumor. We hypothesize that these histologic pitfalls evolve secondary to testicular obstruction by the tumor mass. Recognition of and distinguishing this morphologic mimicry is fundamental to guide appropriate clinical management.
- 22 October 2024
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
Diagnostic incidence and pitfalls of rete testis hyperplasia and hyaline globules in a multi-institutional study of 348 testicular germ cell tumors
Objectives: The concept of rete hyperplasia with hyaline globules simulating testicular yolk sac tumor was first reported in a mostly retrospective review over 30 years ago. Nonetheless, we continue to encounter examples where this scenario resulted in misdiagnosis. Herein, we sought to investigate the incidence of rete hyperplasia/hyaline globules in germ cell tumors and their associated subtypes and hypothesize an etiology. Methods: A consecutive series of 348 germ cell tumor orchiectomies was evaluated for the presence of rete hyperplasia and hyaline globules, with clinicopathologic features recorded. Results: The incidence of rete hyperplasia and/or hyaline globules in our cohort was 30%, with 56% of specimens with rete hyperplasia containing concomitant hyaline globules. Hyaline globules were more often identified in specimens with nonfocal rete hyperplasia (78%) vs focal rete hyperplasia (22%). Absence of a yolk sac tumor component was seen in over half (61%) of orchiectomies with concurrent rete hyperplasia/hyaline globules (n = 105), inclusive of tumors with “pure” subtypes (ie, pure seminoma, pure teratoma, or pure embryonal carcinoma). Of these 105 specimens, rete invasion was seen in only 48%; notably, Paneth cell–like metaplasia was identified in efferent ductules/epididymis in 13%. Conclusions: Rete hyperplasia and hyaline globules are not uncommon findings in the setting of germ cell tumors (including occurrences in various pure/mixed germ cell tumors) and can show striking overlap with yolk sac tumor. We hypothesize that these histologic pitfalls evolve secondary to testicular obstruction by the tumor mass. Recognition of and distinguishing this morphologic mimicry is fundamental to guide appropriate clinical management.
- 1 December 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (12) , e133-e134
Persistent Hypopigmented and Scaly Rash: Challenge
- 1 December 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (12) , e133-e134
Persistent Hypopigmented and Scaly Rash: Challenge
- 1 December 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (12) , 1000-1001
Persistent Hypopigmented and Scaly Rash: Answer
- 1 December 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (12) , 1000-1001
Persistent Hypopigmented and Scaly Rash: Answer
- 15 September 2021
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 49 (2) , 163-166
Urticarial vasculitis: A potential signpost for multisystem inflammatory syndrome in children
Multisystem inflammatory syndrome in children (MIS‐C) is a rare and serious complication of Sars‐Cov‐2 infection. Dermatologic manifestations are present in the majority of patients. Skin lesions found in children with MIS‐C are classified into four categories: morbilliform, reticulated, scarlatiniform, and urticarial lesions. Clinicopathologic characterization within these categories is limited. Thus, we present a clear example of an urticarial lesion in the context of MIS‐C with well‐documented clinicopathologic phenomena. A previously healthy 16‐year‐old female presented with 3 weeks of an itchy, burning rash initially presenting on her right forearm (and lasting greater than 24 hours without migration) before spreading diffusely. She also reported fever, cough, myalgias, nausea, and vomiting of 4 weeks' duration. Physical examination revealed an edematous, maculopapular, nonblanching, erythematous rash covering the patient's upper extremities, abdomen, back, anterior thighs, and face. The patient tested positive for COVID‐19. A low‐grade leukocytoclastic vasculitis was noted along with intraluminal fibrin and rare microthrombi in vessels of the mid to deep dermis. The patient was diagnosed with MIS‐C and urticarial vasculitis. She was treated with steroids and naproxen for subsequent MIS‐C flares. Dapsone treatment was started for the urticarial vasculitis.
- 15 September 2021
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 49 (2) , 163-166
Urticarial vasculitis: A potential signpost for multisystem inflammatory syndrome in children
Multisystem inflammatory syndrome in children (MIS‐C) is a rare and serious complication of Sars‐Cov‐2 infection. Dermatologic manifestations are present in the majority of patients. Skin lesions found in children with MIS‐C are classified into four categories: morbilliform, reticulated, scarlatiniform, and urticarial lesions. Clinicopathologic characterization within these categories is limited. Thus, we present a clear example of an urticarial lesion in the context of MIS‐C with well‐documented clinicopathologic phenomena. A previously healthy 16‐year‐old female presented with 3 weeks of an itchy, burning rash initially presenting on her right forearm (and lasting greater than 24 hours without migration) before spreading diffusely. She also reported fever, cough, myalgias, nausea, and vomiting of 4 weeks' duration. Physical examination revealed an edematous, maculopapular, nonblanching, erythematous rash covering the patient's upper extremities, abdomen, back, anterior thighs, and face. The patient tested positive for COVID‐19. A low‐grade leukocytoclastic vasculitis was noted along with intraluminal fibrin and rare microthrombi in vessels of the mid to deep dermis. The patient was diagnosed with MIS‐C and urticarial vasculitis. She was treated with steroids and naproxen for subsequent MIS‐C flares. Dapsone treatment was started for the urticarial vasculitis.
- 1 May 2021
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 19 (5) , e46-E46
Esophageal Epidermoid Metaplasia: Skin in the Game
- 1 May 2021
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 19 (5) , e46-E46
Esophageal Epidermoid Metaplasia: Skin in the Game
- 26 January 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (10) , 740-745
Fortuitous Eradication of an Aggressive Basal Cell Carcinoma Via Foreign Body Reaction to a Polyurethane Vacuum-Assisted Closure Sponge
The foreign body reaction (FBR) is a well-documented immune reaction. Much of the literature on FBRs has focused on minimizing this immune response to mitigate the impact on medical implants. Here, we present a case that illustrates a serendipitous oncologic outcome from an FBR. A 54-year-old man presented with an aggressive basal cell carcinoma (BCC). At the first resection, he had broadly positive surgical margins. The surgical wound was temporized with a polyurethane wound vacuum assisted closure (VAC) device. He was lost to follow-up having retained a VAC sponge for a total of 12 weeks. A wide re-resection was performed 7 months after the initial resection. Exhaustive examination of the resected specimen was performed. There was an absence of any BCC, replaced by a widespread chronic FBR to polyurethane VAC sponge particles. This suggests that the foreign body immune response was sufficiently intense to eradicate any remaining BCC. This case illustrates the concept of an FBR as a novel method of local immunotherapy.
- 26 January 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (10) , 740-745
Fortuitous Eradication of an Aggressive Basal Cell Carcinoma Via Foreign Body Reaction to a Polyurethane Vacuum-Assisted Closure Sponge
The foreign body reaction (FBR) is a well-documented immune reaction. Much of the literature on FBRs has focused on minimizing this immune response to mitigate the impact on medical implants. Here, we present a case that illustrates a serendipitous oncologic outcome from an FBR. A 54-year-old man presented with an aggressive basal cell carcinoma (BCC). At the first resection, he had broadly positive surgical margins. The surgical wound was temporized with a polyurethane wound vacuum assisted closure (VAC) device. He was lost to follow-up having retained a VAC sponge for a total of 12 weeks. A wide re-resection was performed 7 months after the initial resection. Exhaustive examination of the resected specimen was performed. There was an absence of any BCC, replaced by a widespread chronic FBR to polyurethane VAC sponge particles. This suggests that the foreign body immune response was sufficiently intense to eradicate any remaining BCC. This case illustrates the concept of an FBR as a novel method of local immunotherapy.